This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Frank, S. Articles by Schackert, H. K. Search for Related Content PubMed PubMed Citation Articles by Frank, S. Articles by Schackert, H. K.

The Putative Tumor Suppressor Gene FHIT at 3p14.2 Is Rarely Affected by Loss of Heterozygosity in Primary Human Brain Tumors

Departments of Surgical Research [S. F., J. M., J. P., Ma. H., Mo. H., S. P., H. K. S.] and Neurosurgery [J. H., G. S.], Technical University of Dresden, Fetscherstrasse 74, D-01307 Dresden, Germany

To elucidate the role of the recently identified FHIT gene, located at 3p14.2 in human brain tumor carcinogenesis, a total of 259 tumors were analyzed for loss of heterozygosity (LOH) at microsatellite loci D3S1313, D3S1234, D3S1300, and D3S1481. In primary brain tumors, LOH was detected at a frequency of 8.4% (n = 214). Low-grade gliomas exhibited insignificantly lower LOH rates in comparison to high-grade gliomas (5.3%, n = 19, versus 11.1%, n = 90). Notably, no allelic loss was observed in 12 recurrent glioblastomas analyzed in comparison to their corresponding primary tumor lesions and in two astrocytomas with progression to higher grades of malignancy. Our data indicate that allelic loss of the FHIT gene is neither a critical event in carcinogenesis of primary brain tumors nor tumor grade-associated in astrocytic tumors. In contrast, observed LOH rate for brain metastases was as high as 54.5% (n = 45), in accordance with data thus far accumulated from analyses of corresponding primary tumors.

¹ These authors made equal contributions to this work.

² To whom requests for reprints should be addressed. Phone: 49-351-458-3873; Fax: 49-351-458-4350; E-mail: stfrank@rcs.urz.tu-dresden.de.

Received 1/24/97. Accepted 5/ 3/97.

This article has been cited by other articles:

				M. Hampl, J. A. Hampl, G. Reiss, G. Schackert, H.-D. Saeger, and H. K. Schackert Loss of Heterozygosity Accumulation in Primary Breast Carcinomas and Additionally in Corresponding Distant Metastases Is Associated with Poor Outcome Clin. Cancer Res., June 1, 1999; 5(6): 1417 - 1425. [Abstract] [Full Text] [PDF]